Skip to main content
Caplight Logo









Implicit Bioscience

Implicit Bioscience

Private
Woolloongabba, QueenslandHealthcare & Life Scienceshttps://implicitbioscience.com/

Last Round

Grant

Dec 20, 2020

Total Funding Raised

$735,000

Company Overview

Implicit Bioscience is a biotechnology company developing immunotherapies for inflammatory, infectious, and neurodegenerative diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

monoclonal antibodyimmunomodulationCD14 inhibitoratibuclimabALS treatmentclinical-stage biotechARDS treatmentimmunotherapycardioimmunologymAbbiologic druginnate immunityanti-inflammatory therapydrug in-licensingbiodefense therapeutics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Implicit Bioscience Comparables

Compare Implicit Bioscience with similar companies based on industry and business-model similarity.

Implicit Bioscience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Aqualung Therapeutics Corporation
80%
BioAegis Therapeutics
78%
Edesa Biotech Inc
76%

Implicit Bioscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 20, 2020
VC RoundFeb 25, 2009

Key People

Founding team and executive leadership

Garry Redlich

Chief Executive Officer

Executive Team

Implicit Bioscience Investors

Notable investors and investment history

Implicit Bioscience investors
InvestorRounds
U.S. Department of WarGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 20, 2026

    Monthly visitors increased 123% MoM.

  • Jun 1, 2025

    Monthly visitors increased 140% MoM.

Implicit Bioscience Filings

Explore SEC and related filing metadata, where available.

Implicit Bioscience filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Implicit Bioscience's valuation, stock price, and market status.

Is Implicit Bioscience a public or private company?

Implicit Bioscience is a private company.

What is the current stock price of Implicit Bioscience?

Implicit Bioscience is a private company with no public stock price. No recent secondary market data is available.

How much is Implicit Bioscience worth (valuation)?

Valuation information for Implicit Bioscience is not publicly available.

Can I buy Implicit Bioscience stock?

Implicit Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Implicit Bioscience's last funding round?

Implicit Bioscience's most recent funding round was Grant on December 20, 2020.

Who are the main investors in Implicit Bioscience?

Key investors in Implicit Bioscience include U.S. Department of War.

Will Implicit Bioscience IPO soon?

No public IPO plans have been announced for Implicit Bioscience.

How can I track Implicit Bioscience secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Implicit Bioscience's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersWoolloongabba, Queensland
Employee Range11
Year Founded2004
Last FundingDec 20, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?